COSCIENS Biopharma Inc. – NASDAQ:CSCI

COSCIENS Biopharma stock price today

$2.71
+0.02
+1.12%

COSCIENS Biopharma key metrics

Market Cap
7.92M
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
N/A
Revenue
N/A
EBITDA
N/A
Income
N/A
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

COSCIENS Biopharma stock price history

COSCIENS Biopharma stock forecast

COSCIENS Biopharma financial statements

COSCIENS Biopharma other data

  • What's the price of COSCIENS Biopharma stock today?

    One share of COSCIENS Biopharma stock can currently be purchased for approximately $2.71.

  • When is COSCIENS Biopharma's next earnings date?

    Unfortunately, COSCIENS Biopharma's (CSCI) next earnings date is currently unknown.

  • Does COSCIENS Biopharma pay dividends?

    No, COSCIENS Biopharma does not pay dividends.

  • How much money does COSCIENS Biopharma make?

    COSCIENS Biopharma has a market capitalization of 7.92M.

  • What is COSCIENS Biopharma's stock symbol?

    COSCIENS Biopharma Inc. is traded on the NASDAQ under the ticker symbol "CSCI".

  • What is COSCIENS Biopharma's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of COSCIENS Biopharma?

    Shares of COSCIENS Biopharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does COSCIENS Biopharma have?

    COSCIENS Biopharma Inc. employs 21 workers.

  • When COSCIENS Biopharma went public?

    COSCIENS Biopharma Inc. is publicly traded company for more then 29 years since IPO on 18 Jul 1996.

  • What is COSCIENS Biopharma's official website?

    The official website for COSCIENS Biopharma is cosciensbio.com.

  • Where are COSCIENS Biopharma's headquarters?

    COSCIENS Biopharma is headquartered at 222 Bay Street, Toronto, ON.

  • How can i contact COSCIENS Biopharma?

    COSCIENS Biopharma's mailing address is 222 Bay Street, Toronto, ON and company can be reached via phone at +90 88240775.

COSCIENS Biopharma company profile:

COSCIENS Biopharma Inc.

cosciensbio.com
Exchange:

NASDAQ

Full time employees:

21

Industry:

Biotechnology

Sector:

Healthcare

COSCIENS Biopharma Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests in Canada, Switzerland, Ireland, Denmark, Germany, the United States, and internationally. Its lead product is Macrilen (macimorelin), an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of patients with adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as endocrinology and oncology indications; AEZS-150, a delayed clearance parathyroid hormone fusion polypeptide that is in preclinical trial for the treatment of chronic hypoparathyroidism; and AEZS-130 that is in preclinical trial for the treatment of amyotrophic lateral sclerosis. The company also has a license and research agreement with University of Wuerzburg to develop, manufacture, and commercialize AIM biologicals for the treatment of neuromyelitis optica spectrum disorder; and for pre-clinical development towards the potential treatment of Parkinson's disease. In addition, it has a license agreement with Consilient Health Ltd. and NK MEDITECH Ltd. for the development and commercialization of macimorelin; a distribution and commercialization agreement with Er-Kim Pharmaceuticals Bulgaria Eood for the commercialization of macimorelin for the diagnosis of growth hormone deficiency in children and adults; as well as The University of Sheffield, the United Kingdom for the development, manufacture, and commercialization of parathyroid hormone fusion polypeptides for the treatment of chronic hypoparathyroidism. The company was formerly known as Aeterna Zentaris Inc. and changed its name to COSCIENS Biopharma Inc. in August 2024. COSCIENS Biopharma Inc. was incorporated in 1990 and is headquartered in Toronto, Canada.

222 Bay Street
Toronto, ON M5K 1E7

CIK: 0001113423
ISIN: CA22112H1010
CUSIP: 22112H101